| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8661853 | International Journal of Cardiology | 2018 | 7 Pages |
Abstract
The IL-6R antibody may be more effective in mitigating vascular inflammation and remodeling than CTX via inhibition of IL-6 and MMP-9.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Xiufang Kong, Xiaojie Zhang, Peng Lv, Xiaomeng Cui, Lili Ma, Huiyong Chen, Hao Liu, Jiang Lin, Lindi Jiang,